← Scoopfeeds — Intelligent news, curated.
Earnings call transcript: Gossamer Bio Q1 2026 sees revenue beat, EPS miss
business

Earnings call transcript: Gossamer Bio Q1 2026 sees revenue beat, EPS miss

Investing.com · May 21, 2026, 9:33 PM · Also reported by 4 other sources

Earnings call transcript: Gossamer Bio Q1 2026 sees revenue beat, EPS miss

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance WMS Q4 2026 Earnings Call Transcript Yahoo Finance Hovnanian (HOV) Q2 2026 Earnings Transcript Yahoo Finance EnerSys (ENS) Q4 2026 Earnings Transcript Yahoo Finance Deere & Company Q2 2026 Earnings Call Summary

More in business

Investing.com
Pimco dynamic income strategy fund portfolio manager buys $385,816 in shares
Investing.com
Nektar Therapeutics CEO Robin Howard W sells $29,086 in shares
Investing.com
Nektar Therapeutics R&D chief sells $13,036 in shares
Investing.com
Form 13G GSR V Acquisition Corp. For: 21 May
Investing.com
Quince Therapeutics regains compliance with Nasdaq listing requirements
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop